NEHI – June 25, 2011

Download Report

Transcript NEHI – June 25, 2011

Neuroendocrine cell Hyperplasia of Infancy
(NEHI)
Lisa R. Young, MD
Director, Pediatric Rare Lung Diseases Program
Cincinnati Children’s Hospital Medical Center
ChILD Foundation Conference
June 25, 2011
Chicago
Overview
• What are the initial symptoms of NEHI?
• How do we diagnose NEHI?
• How do we take care of children with NEHI?
• What happens to children with NEHI when
they get older?
• Many more unknowns
NEHI is a relatively recently discovered
disorder and we are still learning about it and
teaching other doctors about it.
• Deterding RR, Fan LL, Morton R, Hay TC, Langston C.
“Persistent tachypnea of infancy (PTI) – a new entity”
Pediatr Pulmonol, 2001.
• Deterding RR, Pye C, Fan LL, et al. Persistent tachypnea of
infancy is associated with neuroendocrine cell hyperplasia.
Pediatr Pulmonol, 2005.
NEHI Symptoms
• Typically presents in term infants in the first year
(or months) of life
• Typical symptoms in early infancy are:
• Tachypnea = fast breathing
• Retractions
• Crackles
• Hypoxia = low oxygen levels
• Failure to thrive / growth difficulties
Deterding et al. Persistent tachypnea of infancy is associated with
neuroendocrine cell hyperplasia. Pediatr Pulmonol. 2005; 40:157-165
NEHI Symptoms: An evolving spectrum
We also sometimes see kids with proven NEHI who:
• were late preterm infants
• have wheezing
• have intermittent symptoms, more than chronic
• seemed well until they had an acute illness
• never need supplemental oxygen
• never have growth / feeding problems
NEHI symptoms also overlap with many
other causes of lung disease.
• Physicians must ‘rule-out’ other more
common disorders first.
• But sometimes other more common
problems can also complicate the picture.
• Reflux
• Acute infections, including viral illnesses
• Occasionally patients may be misdiagnosed
with NEHI.
What are the tests that enable a
confident diagnosis of NEHI?
• Radiology studies
• Infant pulmonary function tests (infant
PFTs)
• Lung biopsy
 The term ‘NEHI Syndrome’ has been proposed for
children who have chest CTs suggesting NEHI but who
have not had a biopsy for confirmation.
Chest x-rays in NEHI
• May be:
• Normal
• Hyperinflated
• Look like a viral
infection or bronchiolitis
Deterding et al, 2005
Chest CT scans in NEHI
• May be diagnostic for NEHI in many cases
• Technical aspects of how the scan is done can be
very important
• May be atypical in at least 1/5 of children proven to
have NEHI by lung biopsy (Brody et al, AJR 2010)
Chest HRCT findings in NEHI include geographic
ground glass opacities, most prominent in the RML and
lingula, and significant air-trapping.
Importantly, no other significant abnormalities should be present.
Brody et al, AJR 2010
Examples of CT scans in NEHI
‘TYPICAL’ for
NEHI
NOT ‘TYPICAL’ for NEHI
Brody and Crotty, 2008; Brody et al, 2010; Young et al, 2010
Infant PFTs in NEHI
• May aid the diagnosis of NEHI in some cases
• Kerby et al (2009):
• Mixed physiologic pattern in NEHI with air-trapping
• Distinct from other ILD
• Young et al (2010):
• Severity of small airway obstruction on iPFT may
correlate with extent of neuroendocrine cells seen in the
biopsy
• Other studies ongoing
Lung biopsies in NEHI
Example of normal lung structures when
viewed under the microscope
Example of normal lung from a lung biopsy
when viewed under the microscope
Example of a normal bronchiole
(“small air tube”) when viewed under the microscope
Lung biopsies look nearly normal in NEHI.
Bombesin staining identifies increased numbers of
neuroendocrine cells (NECs)
Bronchiole with NECs Neuroendocrine body (NEB)
Provided by Gail Deutsch, MD
Where are the neuroendocrine cells?
In NEHI, the NEC prominence is greatest in the distal
respiratory bronchioles, and distinguishes NEHI cases from
other disorders associated with NEC hyperplasia.
Young et al, 2010
NEHI: Variable numbers of neuroendocrine
cells in different airways
Deutsch et al, AJRCCM 2007
In NEHI, there is wide intra and inter-subject
variability in NEC number, which does not correlate
with the imaging appearance of the region biopsied.
Young et al, Chest , 2010
How do we take care of children with NEHI?
• There are no proven medications.
• Corticosteroids (Prednisone) do not help in
most cases.
• Bronchodilators (breathing treatments) don’t
help most long-term.
How do we take care of children with NEHI?
• Supplemental oxygen when needed
• Nutritional support when needed
• Treat other problems as they arise, such as
reflux or infections.
• Avoid injuries to the lung.
• Flu shot each year
• Synagis to try to prevent RSV?
• Avoid cigarette smoke exposure
How do we take care of children with NEHI?
• Team approach
• Different team members may be needed for different kids and
families.
• Care coordination can be very important
• Psychosocial support for families
• Childcare and school considerations
How do we monitor children with NEHI?
• Monitoring of oxygen saturations
• Monitoring of growth
• Routine follow-up chest x-rays and repeat CT
scans usually not helpful / not recommended.
• May be needed if/when children are acutely ill or
clinical course is atypical.
• Infant PFTs may have a role.
What happens to children with NEHI as they get older?
• Improvement over time but variable speed
• May require supplemental oxygen for years
• Favorable long-term outcome
What happens to children with NEHI as they get older?
• At least some older children have with NEHI have
abnormal PFTs and exercise intolerance.
• Some exacerbate with respiratory infection.
• Possible relationship to adult lung disorders is
unknown.
WE NEED MORE DATA!
THIS IS A BIG AREA WHERE THE REGISTRY CAN HELP.
Many unanswered questions about NEHI
• Why do children with NEHI often need
supplemental oxygen?
– What are the criteria for using oxygen in kids with NEHI?
Many unanswered questions about NEHI
• Why do children with NEHI have crackles?
Many unanswered questions about NEHI
• Does nutritional status and growth impact lung
function in NEHI?
Many unanswered questions about NEHI
• Why do some children with NEHI have ‘atypical’
chest CTs and does it matter?
• Why are some children with NEHI ‘sicker’ than
others?
How will we discover what causes NEHI
and how to treat (or prevent) it?
Genetic basis?
What is the function of (or dysfunction) of
neuroendocrine cells in NEHI?
Are other cells involved, and what happens in lung
development in children with NEHI?
Acknowledgements
Rare Lung Diseases Program
Connie Meeks, RN
Jackie Taylor, RD
Allison Whisenhunt, MISW
Brenda McMillan (coordinator)
Robert E. Wood, PhD, MD
Bruce Trapnell, MD
Infant PFTs:
Jim Acton, MD (Missouri)
Karen McDowell, MD
Beth Koch, RRT
Pathology:
Todd Boyd, DO
Gail Deutsch, MD (Seattle)
Radiology:
Alan Brody, MD
Eric Crotty, MD
Mantosh Rattan, MD
Pediatric Surgery:
Thomas Inge, MD, PhD
Children’s Interstitial Lung Disease
Research Network